CCI clears Advent’s ₹3,150-crore investment in Yatharth Hospitals
In short
The Competition Commission of India approved Advent’s ₹3,150-crore investment in Yatharth Hospitals. Advent will buy a 24.9% stake through new capital, and the hospital chain wants to expand beyond 5,000 beds.
The approval removes a major regulatory hurdle for the deal. It also supports Yatharth Hospitals’ growth plans.
What the reporting says
The Competition Commission of India approved Advent’s ₹3,150-crore investment in Yatharth Hospitals, allowing the US private equity firm to acquire a 24.9% stake through a primary capital infusion. The approval clears a key regulatory step for the transaction.
Why it matters
The Competition Commission of India has approved Advent’s ₹3,150-crore investment in Yatharth Hospitals. The US private equity firm is set to take a 24.9% stake through a primary capital infusion. The transaction is linked to Yatharth Hospitals’ expansion plans beyond 5,000 beds, making the clearance important for the hospital chain’s growth strategy and for Advent’s entry into the business.